UC Berkeley and Howard Hughes Medical InstituteJennifer Doudna is professor in the Department of Chemistry and Chemical Engineering and the Department of Molecular and Cell Biology at the University of California, Berkeley. Doudna has been an investigator with the Howard Hughes Medical Institute (HHMI) since 1997, and since 2018 holds the position of senior investigator at the Gladstone Institutes as well as that of professor at the University of California, San Francisco.
Doudna has been a leading figure in what is referred to as the "CRISPR revolution" for her fundamental work and leadership in developing CRISPR-mediated genome editing. In 2012, Doudna and Emmanuelle Charpentier were the first to propose that CRISPR/Cas9 (enzymes from bacteria that control microbial immunity) could be used for programmable editing of genomes, which is now considered one of the most significant discoveries in the history of biology.
[Video] CRISPR Systems: From adaptive immunity to genome editing Presentation at the Molecular Frontiers Symposium in Stockholm 2017